Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Macdonald, S. Smalley, J. Benedetti, S. Hundahl, N. Estes, G. Stemmermann, D. Haller, J. Ajani, L. Gunderson, M. Jessup (2001)
Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. Results of intergroup study INT-0116 (SWOG 9008)European Journal of Cancer, 37
S. Folli, M. Dente, D. Dell'amore, M. Gaudio, O. Nanni, L. Saragoni, A. Vio (1995)
Early gastric cancer: Prognostic factors in 223 patientsBritish Journal of Surgery, 82
J. Pignon, M. Ducreux, P. Rougier (1994)
Meta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 4
P. Correa, W. Haenszel (1982)
Epidemiology of Gastric Cancer
A. Einzig, S. Lipsitz, P. Wiernik, A. Benson (1995)
Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT)Investigational New Drugs, 13
N. Boku, A. Ohtsu, Yasuhiro Shimada, K. Shirao, S. Seki, Hiroshi Saito, Yuh Sakata, I. Hyodo (1999)
Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 1
A. Einzig, D. Neuberg, S. Remick, D. Karp, P. O'dwyer, J. Stewart, A. Benson (1996)
Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) Results of Protocol E1293Medical Oncology, 13
Arnaud Roth, R. Maibach, Nicola Fazio, C. Sessa, R. Stupp, R. Morant, Richard Herrmann, M. Borner, A. Goldhirsch, F. Braud (2004)
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial.Annals of oncology : official journal of the European Society for Medical Oncology, 15 5
L. Gunderson, H. Sosin (1982)
Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.International journal of radiation oncology, biology, physics, 8 1
H. Hartgrink, C. Velde, H. Putter, I. Songun, I. Songun, M. Tesselaar, E. Kranenbarg, J. Vries, J. Wils, J. Bijl, J. Krieken (2004)
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 30 6
P. Mansfield, A. Lowy, B. Feig (2000)
Preoperative chemoradiation for potentially resectable gastric cancer [abstract no. 955]Proc Am Soc Clin Oncol, 19
B. Neri, G. Cini, F. Andreoli, B. Boffi, D. Francesconi, R. Mazzanti, F. Medi, A. Mercatelli, S. Romano, L. Siliani, R. Tarquini, R. Moretti (2001)
Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-upBritish Journal of Cancer, 84
J. Macdonald, P. Woolley, Tariyln Smythe, W. Ueno, D. Hoth, P. Schein (1979)
5‐fluorouracil, adriamycin, and mitomycin‐c (fam) combination chemotherapy in the treatment of advanced gastric cancerCancer, 44
T. Kajitani (1981)
The general rules for the gastric cancer study in surgery and pathology. Part I: clinical classificationJpn J Surg, 11
Moertel Cg, D. Childs, J. O'fallon, Margaret Holbrook, A. Schutt, R. Reitemeier (1984)
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2 11
A. Cuschieri, V. Joypaul, P. Fayers, P. Cook, J. Fielding, J. Craven, J. Bancewicz (1996)
Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trialThe Lancet, 347
P. Engstrom, P. Lavin, H. Douglass, K. Brunner (1985)
Postoperative adjuvant 5‐fluorouracil plus methyl‐CCNU therapy for gastric cancer patients. Eastern cooperative oncology group study (EST 3275)Cancer, 55
Yeul-Hong Kim, S. Shin, B. Kim, Jin Kim, J. Kim, Y. Mok, Chong‐Suk Kim, Hosung Rhyu, J. Hyun, J. Kim (1999)
Paclitaxel, 5‐fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinomaCancer, 85
S. Cascinu, R. Ficarelli, M. Safi, F. Graziano, G. Catalano, R. Cellerino (1997)
A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer.European journal of cancer, 33 10
A. Bunt, J. Hermans, M. Boon, C. Velde, M. Sasako, G. Fleuren, J. Bruijn (1994)
Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 2
D.M Parkin (1998)
Epidemiology of cancer: global patterns and trends.Toxicology letters, 102-103
G. Higgins, J. Amadeo, D. Smith, E. Humphrey, R. Keehn (1983)
Efficacy of prolonged intermittent therapy with combined 5‐FU and methyl‐CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group reportCancer, 52
K. Hennin, P. Thuss-Patience, R. Catane (1999)
Final results of a phase II trial of CPT-11 in patients with advanced gastric cancer [abstract no. 993]Proc Am Soc Clin Oncol, 18
L. Saltz, M. Rubin, H. Hochster (2001)
Cetuximab (IMC-C225) plus irinotecan (CPT-11) is active in CPT-11-refractory colorectal cancer (CRC) that expresses epidermal growth factor receptor (EGFR) [abstract no. 710]Proc Am Soc Clin Oncol, 20
J. Hermans, J. Bonenkamp, M. Boon, A. Bunt, S. Ohyama, M. Sasako, C. Velde (1993)
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 11 8
A. Webb, D. Cunningham, J. Scarffe, P. Harper, A. Norman, J. Joffe, M. Hughes, J. Mansi, M. Findlay, A. Hill, J. Oates, M. Nicolson, T. Hickish, M. O'Brien, T. Iveson, M. Watson, C. Underhill, A. Wardley, M. Meehan (1997)
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 1
K. Dolan, R. Sutton, S. Walker, A. Morris, F. Campbell, E. Williams (1999)
New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiologyBritish Journal of Cancer, 80
J. Ajani, P. Mansfield, N. Janjan, J. Morris, P. Pisters, P. Lynch, B. Feig, R. Myerson, R. Nivers, Deborah Cohen, L. Gunderson (2004)
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 14
M. Hallissey, J. Dunn, L. Ward, W. Allum, British Group (1994)
The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-upThe Lancet, 343
Lars-Erik Hansson, P. Sparén, O. Nyrén (1999)
Survival in stomach cancer is improving: results of a nationwide population-based Swedish study.Annals of surgery, 230 2
A.D. Roth, R. Maibach, S. Falk (2004)
Docetaxel-cisplatin-5FU (TCF) versus docetaxel-cisplatin (TC) versus epirubicin-cisplatin-5FU (ECF) as systemic treatment for advanced gastric carcinoma (AGC): a randomized phase II trial of the Swiss Group for Clinical Cancer Research (SAKK) [abstract no. 4020]Proc Am Soc Clin Oncol, 23
I. Panzini, L. Gianni, P. Fattori, D. Tassinari, M. Imola, P. Fabbri, V. Arcangeli, G. Drudi, D. Canuti, F. Fochessati, A. Ravaioli (2002)
Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.Tumori, 88 1
A. Cuschieri, S. Weeden, J. Fielding (1999)
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative GroupBr J Cancer, 79
K. Maruyama, P. Gunvén, K. Okabayashi, M. Sasako, T. Kinoshitá (1989)
Lymph node metastases of gastric cancer. General pattern in 1931 patients.Annals of surgery, 210 5
M. Findlay, V. Ackland, V. Gebski (2001)
Phase II study of irinotecan, leucovorin and 5FU (ILF) in advanced gastric cancer [abstract no. 655]Proc Am Soc Clin Oncol, 20
A. Roth, R. Maibach, S. Falk, R. Stupp, P. Saletti, D. Kãberle, M. Borner, H. Honegger, M. Leslie, N. Fazio (2004)
Docetaxel-cisplatin-5FU (TCF) versus docetaxel-cisplatin (TC) versus epirubicin-cisplatin-5FU (ECF) as systemic treatment for advanced gastric carcinoma (AGC): A randomized phase II trial of the Swiss Group for Clinical Cancer Research (SAKK).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 14_suppl
J. Wils, H. Klein, D. Wagener, H. Bleiberg, H. Reis, F. Korsten, T. Conroy, M. Fickers, S. Leyvraz, M. Buyse (1991)
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 9 5
J. Soga, Kiyoo Kobayashi, Juichi Saito, M. Fujimaki, T. Muto (1979)
The role of lymphadenectomy in curative surgery for gastric cancerWorld Journal of Surgery, 3
W. Allum, M. Hallissey, LC Ward, M. Hockey (1989)
A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group.British Journal of Cancer, 60
T. Kajitani, The Cancer (1981)
The general rules for the gastric cancer study in surgery and pathologyThe Japanese journal of surgery, 11
Masayoshi Mai, Yuh Sakata, Ryunosuke Kanamaru, Minoru Kurihara, M. Suminaga, J. Ota, N. Hirabayashi, Tetsuo Taguchi, H. Furue (1999)
[A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].Gan to kagaku ryoho. Cancer & chemotherapy, 26 4
A. Cuschieri, S. Weeden, J. Fielding, J. Bancewicz, J. Craven, V. Joypaul, M. Sydes, P. Fayers, for group (1999)
Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trialBritish Journal of Cancer, 79
Wansik Yu, I. Whang, Insoo Suh, A. Averbach, D. Chang, P. Sugarbaker (1998)
Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.Annals of surgery, 228 3
U. Vanhoefer, P. Rougier, H. Wilke, M. Ducreux, Á. Lacave, E. Cutsem, M. Planker, José santos, P. Piedbois, B. Paillot, H. Bodenstein, H. Schmoll, H. Bleiberg, B. Nordlinger, M. Couvreur, B. Baron, J. Wils (2000)
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment ofJournal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 14
K. Maruyama, K. Okabayashi, T. Kinoshitá (1987)
Progress in gastric cancer surgery in Japan and its limits of radicalityWorld Journal of Surgery, 11
A.I. Einzig, S. Lipsitz, P.H. Wiernik (1995)
Phase II trial of Taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT): the Eastern Cooperative Oncology group (ECOG) resultsInvest New Drugs, 13
K. Shirao, Y. Shimada, Hitoshi Kondo, Daizo Saito, T. Yamao, Hiromi Ono, Tadashi Yokoyama, Haruhiko Fukuda, M. Oka, Y. Watanabe, Atsushi Ohtsu, N. Boku, T. Fujii, Yasushi Oda, K. Muro, Shigeaki Yoshida (1997)
Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 3
J. Macdonald, T. Fleming, R. Peterson, J. Berenberg, S. McClure, R. Chapman, H. Eyre, D. Solanki, A. Cruz, R. Gagliano, N. Estes, C. Tangen, S. Rivkin (1995)
Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A southwest oncology group studyAnnals of Surgical Oncology, 2
Carsten Bokemeyer, C. Lampe, M. Clemens, J. Hartmann, Detlev Quietzsch, L. Forkmann, C. Kollmannsberger, Lothar Kanz (1997)
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer.Anti-cancer drugs, 8 4
J. Anido, J. Albanell, F. Rojo (2001)
Inhibition by ZD1839 (iressa) of epidermal growth factor (EGF) and heregulin induced signaling pathways in human breast cancer cells, [abstract no. 1712]Proc Am Soc Clin Oncol, 20
J. Macdonald, S. Smalley, J. Benedetti, S. Hundahl, N. Estes, G. Stemmermann, D. Haller, J. Ajani, L. Gunderson, J. Jessup, J. Martenson (2001)
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionThe New England Journal of Medicine, 345
J. Ajani, J. Fairweather, P. Dumas, Y. Patt, Richard Pazdur, Paul Mansfield (1998)
Phase II study of Taxol in patients with advanced gastric carcinoma.The cancer journal from Scientific American, 4 4
A. Webb, D. Cunningham, F. Cotter, P. Ross, J. Walters, I. Judson, F. Raynaud, P. Clarke, Z. Dziewanowska (1997)
First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trialEuropean Journal of Cancer, 33
A. Hagiwara, Toshio Takahashi, O. Kojima, K. Sawai, T. Yamaguchi, T. Yamane, H. Taniguchi, K. Kitamura, A. Noguchi, K. Seiki, C. Sakakura (1992)
Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancerThe Lancet, 339
D. Cunningham, W.H. Allum, S.P. Stenning (2005)
Perioperative chemotherapy in operable gastric and lower oesophageal cancer: final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) [abstract no. 4001]Proc Am Soc Clin Oncol, 23
J.J. Bonenkamp, J. Hermans, M. Sasako (1999)
Extended lymph-node dissection for gastric cancer: Dutch Gastric Cancer GroupN Engl J Med, 340
A. Murad, Flavia Santiago, A. Petroianu, Paulo Rocha, M. Rodrigues, M. Rausch (1993)
Modified therapy with 5‐fluorouracil, doxorubicin, and methotrexate in advanced gastric cancerCancer, 72
Wansik Yu, I. Whang, H. Chung, A. Averbach, P. Sugarbaker (2001)
Indications for Early Postoperative Intraperitoneal Chemotherapy of Advanced Gastric Cancer: Results of a Prospective Randomized TrialWorld Journal of Surgery, 25
Bruno Neri, V. Leonardis, Salvatore Romano, F. Andreoli, L. Pernice, L. Bruno, D. Borrelli, A. Valeri, S. Fabbroni, C. Intini, G. Cini (1996)
Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.British Journal of Cancer, 73
A. Roth, R. Maibach, G. Martinelli, N. Fazio, M. Aapro, O. Pagani, R. Morant, M. Borner, R. Herrmann, H. Honegger, F. Cavalli, P. Alberto, M. Castiglione, A. Goldhirsch (2000)
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).Annals of oncology : official journal of the European Society for Medical Oncology, 11 3
W. Dixon, W. Longmire, W. Holden (1971)
Use of Triethylenethiophosphoramide as an Adjuvant to the Surgical Treatment of Gastric and Colorectal Carcinoma: Ten‐Year Follow‐upAnnals of Surgery, 173
Bonenkamp Jj, J. Hermans, M. Sasako, van Cj, K. Welvaart, I. Songun, S. Meyer, J. Plukker, P. Vanelk, H. Obertop, D. Gouma, Van Jj, C. Taat, de Pw, von Mf, H. Tilanus (1999)
Extended lymph-node dissection for gastric cancer.The New England journal of medicine, 340 12
A. Nashimoto, T. Nakajima, H. Furukawa, M. Kitamura, T. Kinoshitá, Y. Yamamura, M. Sasako, Y. Kunii, H. Motohashi, Seiichiro Yamamoto (2003)
Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 12
K. Futatsuki, A. Wakui, I. Nakao, Y. Sakata, M. Kambe, Y. Shimada, M. Yoshino, T. Taguchi, N. Ogawa (1994)
[Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].Gan to kagaku ryoho. Cancer & chemotherapy, 21 7
U. Vanhoefer, P. Rougier, H. Wilke (2000)
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative GroupJ Clin Oncol, 18
A. Sulkes, J. Smyth, C. Sessa, LY Dirix, J. Vermorken, S. Kaye, J. Wanders, H. Franklin, N. Lebail, J. Verweij, for Group (1994)
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.British Journal of Cancer, 70
C. DENT, Mmed Werner, Frcr Novis, Mrcp Cheverton, M. Brice, Professor Louw (1979)
Prospective randomized trial of combined oncological therapy for gastric carcinomaCancer, 44
M. Degiuli, M. Sasako, A. Ponzetto, T. Allone, T. Soldati, M. Calgaro, F. Balcet, R. Bussone, F. Olivieri, D. Scaglione, F. Danese, M. Morino, P. Calderini, L. Capussotti, G. Fronda, M. Garavoglia, L. Locatelli, M. Dellepiane, F. Rossini, F. Calvo (1997)
Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 23 4
J. Griffith, H. Sue-Ling, I. Martin, M. Dixon, M. McMahon, A. Axon, D. Johnston (1995)
Preservation of the spleen improves survival after radical surgery for gastric cancer.Gut, 36
H. Wanebo, B. Kennedy, J. Chmiel, G. Steele, Winchester Dp, R. Osteen (1993)
Cancer of the stomach. A patient care study by the American College of Surgeons.Annals of surgery, 218 5
E. Cutsem, V. Moiseyenko, S. Tjulandin, M. Fodor, C. Boni, E. Zuber, S. Assadourian (2003)
51A Docetaxel (D), cisplatin (C) 5-fluorouracil (F) compared to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325)Ejc Supplements, 1
H. Wilke, Peter Preusser, Ulrich Fink, U. Gunzer, H. Meyer, J. Meyer, J. Siewert, W. Achterrath, L. Lenaz, H. Knipp (1989)
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 7 9
M. Lise, D. Nitti, M. Buyse, G. Cartei, A. Fornasiero, J. SANTOS, N. Duez (1988)
Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 110
D. Kelsen, O. Atiq, L. Saltz, D. Niedzwiecki, D. Ginn, D. Chapman, R. Heelan, C. Lightdale, V. Vinciguerra, M. Brennan (1992)
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10 4
R. Coombes, P. Schein, C. Chilvers, J. Wils, G. Beretta, J. Bliss, A. Rutten, D. Amadori, H. Cortés-Funes, A. Villar-Grimalt (1990)
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 8 8
W. Allum, D. Cunningham, S. Weeden (2003)
Perioperative chemotherapy in operable gastric and lower oesophageal cancer: a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) [abstract no. 998]Proc Am Soc Clin Oncol, 22
Peter McCulloch, Marcelo Nita, Hussain Kazi, J. Gama-Rodrigues (2003)
Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.The Cochrane database of systematic reviews, 4
磨伊正義 (1999)
A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer : a cooperative study group trial (group B), 26
S. Hundahl, H. Menck, E. Mansour, D. Winchester (1997)
The national cancer data base report on gastric carcinomaCancer, 80
S. Hundahl, J. Macdonald, J. Benedetti, T. Fitzsimmons, Southwest Intergroup (2002)
Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatmentAnnals of Surgical Oncology, 9
J. Ajani, J. Fairweather, P. Pisters, Chulsip Charnsangavej (2000)
Irinotecan and cisplatin in advanced gastric or gastroesophageal junction carcinoma.Oncology, 14 12 Suppl 14
E. Mari, I. Floriani, A. Tinazzi, A. Buda, M. Belfiglio, M. Valentini, S. Cascinu, S. Barni, R. Labianca, V. Torri (2000)
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).Annals of oncology : official journal of the European Society for Medical Oncology, 11 7
H. Rosen, G. Jatzko, S. Repše, S. Potrč, H. Neudorfer, P. Sandbichler, J. Zacherl, H. Rabl, P. Holzberger, P. Lisborg, M. Czeijka (1998)
Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 8
P. Rougier, J. Wils, H. Wilke, Á. Lacave, E. Cutsem, U. Vanhöfer, T. Sahmoud, D. Curran, A. Marinus (1995)
546 Advanced gastric cancer: Comparison of FAMTX (5FU, adriamycine, methotrexate) versus elf (etroposide, 5 FU, leucovorin) versus FUP (infusional 5 FU + cisplatin). Results from an eortc trial of the GITCCG and the arbeitsgemeinschaft für innere onkologie (AIO)European Journal of Cancer, 31
Michael Findlay, David Cunningham, A. Norman, Janine Mansi, Marianne Nicolson, T. Hickish, V. Nicolson, A. Nash, N. Sacks, H Ford, R. Carter, A. Hill (1994)
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).Annals of oncology : official journal of the European Society for Medical Oncology, 5 7
D. Cunningham, W. Allum, S. Stenning, S. Weeden, Tncriugiccsg for (2005)
Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971)Journal of Clinical Oncology, 23
J. DOUGLASS, PhD Stablein, MD Bruckner, MD Kabakow, R. Storch, MD O’Connell, MD Schutt, MD Rubin, MD Moertel, MD McIlrath, MD Weiland, R. Hahn, Mayo, MD Livstone, MD Wright, A. Knowlton, MD Marsh, M. Ropka, Meyer Rn, MD Mayer, MD Lokich, MD Brooks, J. Corson (1982)
Controlled trial of adjuvant chemotherapy following curative resection for gastric cancerCancer, 49
A. Cuschieri, P. Fayers, J. Fielding (1996)
Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial: The Surgical Cooperative GroupLancet, 347
C. Earle, J. Maroun, Dana Farber (1999)
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials.European journal of cancer, 35 7
V. Budach (1994)
The role of radiation therapy in the management of gastric cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 5 Suppl 3
Despite its declining incidence, gastric cancer remains one of the leading causes of cancer-related death worldwide. The definitive management of localized gastric cancer has been the center of much international controversy over the years; surgery remains the mainstay, with debate centering on the required extent of lymph node resection. The role of adjuvant chemotherapy has been studied for decades, but because trials have been underpowered, it has been difficult to demonstrate a statistically significant benefit. Recently, four large meta-analyses have been published on adjuvant chemotherapy in gastric cancer. The first three have been criticized for their methodology, but the most recent meta-analysis was well conducted and showed a statistically significant benefit in favor of adjuvant chemotherapy. The heterogeneity of chemotherapy schedules included in this meta-analysis, however, makes it difficult to define the current standard. Randomized trials in the metastatic setting have shown that the combinations of epirubicin, cisplatin, and infusional fluorouracil (ECF) and docetaxel, cisplatin, and fluorouracil (TCF) have demonstrated superiority over other regimens. The role of preoperative chemotherapy is currently under investigation, with results from the MAGIC (Medical Research Council Adjuvant Gastric Infusional Chemotherapy) trial demonstrating a significant improvement in resectability, progression-free survival, and overall survival with perioperative therapy in patients with operable gastric cancer. Postoperative chemoradiotherapy has also been adopted as a standard of care in the US following the publication of the results of the Intergroup Study, INT-0116, although there remains debate over the relative benefits of more radical surgery versus the use of radiation with adjuvant treatment. It is clear that adjuvant therapy is now an appropriate addition to surgery, although there are still further questions regarding the optimal protocols.
American Journal of Cancer – Springer Journals
Published: Aug 9, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.